DatasetName,NBEAL2_S(1078) NBEAL2_S(1081) NBEAL2_S(2013) NBEAL2_S(2555) NBEAL2_S(2709) NBEAL2_S(2712) NBEAL2_T(1869) NBEAL2_T(2009),NBEAL2_S(1640) NBEAL2_S(1647) NBEAL2_S(2027) NBEAL2_S(2208) NBEAL2_S(2736) NBEAL2_S(2737) NBEAL2_S(2739) NBEAL2_S(2742) NBEAL2_S(2743) NBEAL2_S(39) NBEAL2_S(757) NBEAL2_S(759) NBEAL2_S(770) NBEAL2_T(1867) NBEAL2_T(2746),NBEAL2_S(1301) NBEAL2_S(2012) NBEAL2_S(3) NBEAL2_S(935)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,,0.5282095983741228,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,0.4958378912658258,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,0.5050959822188948,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,,0.5049139537404729,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,0.4972314893115031,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,0.5095287439941596,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,0.609652152186677,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,,0.5040238487916352,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.6092054090517875,,
WZ2023_Pu_010_30min,0.6101387339242509,0.492907702951532,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,0.509786934298577,
RB2022_8_RecoveryEndurance,,,
KBE2022_Log2_Ex_14_U,,0.5092550335758744,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,,0.49491175020087347,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,0.5199654582173776,
RB2022_5_PreSprint,,,
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,,0.5066133292050731,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,,0.5189038984659546,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.6200176959497041,,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,,
GF2025_P6_Sph,,,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,,0.5059361822291896,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.6079195432747599,0.5065644012131199,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,0.6085776154273124,,
KBE2022_Log2_Ex_34_U,,0.512264498950573,
WZ2023_Pu_005_10min,0.6105352616639481,0.49576416594494804,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,,0.5010344147674908,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.6087019549694233,0.5006184080442548,
AH2018_SILAC_MR_2_X,,0.4987761150214843,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,,0.48366008290015405,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,,,
CR2017_Ratio Replicate 1.3,,0.4932927192110409,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,,0.5008831291496318,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,0.5110951547719039,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,,0.4932495135309885,
AH2018_LFQ_1_C,,0.5038429381573709,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,,0.5126169343996195,
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.6087686635881793,0.4984309368632497,
CK2022_11 40-1,,0.5017350658088423,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,0.505844376695874,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,0.5045740960807574,
FSO2013_Ratio H/L normalized Rep2,,0.4993716350970588,
WZ2023_Pu_005_20min,0.6112111275150951,0.5023609531930503,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,,0.4882771755041035,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,0.5057513935707401,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,,0.5311385652775092,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,0.5026014682070309,
CK2022_1 200-1,,0.5033351104317304,
PG2020_Intensity Mock_10h_D,,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.6081435061247,,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,,0.5215222152036695,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,,0.5090283810438837,
KBE2022_Log2_Ex_8_T,,0.5089485998265301,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,,0.5004122452704408,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,,0.5048162777635922,
CK2022_3 40-1,,0.5017592962356593,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,,0.5281534257106029,
HH2022_Reporter intensity 8,,0.5114207353075642,
ZQ2022_N2,,0.4968470234074743,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,,0.49752462393116453,
EJN2021_5_Rest_Basal,,,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,0.5030752158249585,
YA2020_Reporter_intensity_Normal_No.1,,0.525839283604532,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,,0.5085394865739854,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,,,
HS2024_8_I_T3,,,
CF2017_EOC 3,,0.5012785804088401,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,,,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.6088716805694532,0.5003809924994236,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,,0.5012909471506565,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,0.4945579307585932,
KS2014_Intensity N3,,0.5069260118578032,
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,0.5081618774861087,
FSO2013_Ratio H/M normalized Rep2,,0.5151485886305249,
RAM2015_Log2 A,0.6071185299945087,,
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,,
KS2014_Intensity E15_2,,0.5036021446847081,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,,0.5012227183682005,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,,0.5140805697434075,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,0.5053930224627469,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,0.6116971315135209,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.6099413762642976,,
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,,0.5108353586363028,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,,0.406639804177398
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,,
AH2018_SILAC_IT_3_X,,0.509264307070474,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,,0.5083640765335756,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,0.5135640890282687,
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,,0.5016115722502138,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,0.49661130341704496,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,0.5013078150963588,
DL2023_control-1,,,
AR2021_ALG 10 μM,0.6187871912889397,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,0.5038378453091868,
EJN2021_4_Rest_Ins,,,
RN2012_H05,,0.5107706012362578,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,,,
HH2022_Reporter intensity 3,,0.4931203022546065,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,0.5075986700169405,
JW2021_After_3,,,
GF2025_P8_Sph,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,0.510611182560043,
CK2022_11 200-1,,0.5044067700069376,
CK2022_12 200-1,,0.5038918726153149,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,0.50969799507193,
WZ2023_Su_010_20min,0.6102035105310497,0.5031665709489269,
AH2018_TMTMS2_2_N,,0.4979734197595985,0.41289374668785606
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,0.5109208066965818,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,,
AH2018_TMTMS3_Pool,,0.5004239060034185,
KS2014_Intensity N4,,0.5033232495085457,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,0.5077263710903173,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,,0.5027214876763836,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,,0.49625151034662174,
AST2020_anti-CD3+PDL2.2,0.6106736985353017,,
PG2020_Intensity Mock_10h_A,,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,0.5027569804977217,
GF2025_P1_Adh,,,
GF2025_P1_Sph,,,
EJN2021_5_Ex_Basal,,,
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.6072532808000555,0.4952583442210027,
CF2017_EOC 1,,0.508253761819301,
CK2022_3 200-1,,0.5030920805109661,
AH2018_LFQ_IT_3_C,,0.5057556768308046,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,,0.5016228497416538,
RB2022_1_PostSprint,,,
CK2022_4 200-1,,0.5032640107399574,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,0.495024646478063,
AR2021_ALG 1 μM,0.6091937939947328,,0.4070195759230588
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,,0.5363039751305788,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,,,
CK2022_9 16-1,,0.5022229080456468,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,,0.5034247433844,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,0.4935190454760637,
CK2022_16 16-1,,0.504500148447247,
FS2019_db/db3,,,
CK2022_15 40-1,,0.5023190008228214,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.609188555467556,0.5022060961185272,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,0.5112887000117868,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,0.5058071233239821,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,,0.49853214195289175,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,,0.5109501596679668,
AH2018_LFQ_M_1_N,,0.5106039696665022,
KBE2022_Log2_Ex_27_U,,0.5110028099644375,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,,0.5083492622772866,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,,0.5281620386815521,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,0.5030321613052281,
RN2012_L13,,0.5073604022364937,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,0.5077145980268433,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5075616608245475,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,,0.5011873713918805,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,,0.5017717810080851,
HH2022_Reporter intensity 6,,0.5157557056992538,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,0.5113824162815112,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,,0.4983913229687221,0.4215087194491102
GF2025_P3_Adh,,,
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,,0.49452678675062883,0.4060876011554921
RM2024_Intensity D0-1___2,,,
LY2019_P4+,,0.5050871339466589,
KBE2022_Log2_Ex_19_U,,0.512960431132656,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,,0.5149353722208195,
AST2020_Control,0.6087285855585067,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5152472027260333,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,,,
YA2020_Reporter_intensity_Normal_No.3,,0.526162850081448,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,,0.5063365997957975,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,0.5005236955932321,
HH2022_Reporter intensity 1,,0.49258990140838077,
HH2022_Reporter intensity 2,,0.49177128435710443,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,0.5227645762608156,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.6168505759086618,,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,,0.4892639678826024,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,0.526815590390182,
AR2021_KD 72h,,,0.4193005684715519
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,,0.5083199130394213,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,,0.49889952485995714,
KBE2022_Log2_Ex_9_U,,0.5090682182114817,
AH2018_SILAC_M_3_N,,0.5033475601694578,
KBE2022_Log2_Ex_13_T,,0.5077292685776452,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,,,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,,,
RN2012_L12,,0.502907752017928,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,0.5002300665834929,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5020927938798166,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,,0.4973049024882539,
RB2022_7_RecoveryEndurance,,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,,
TM2022_S2.12h.B,,,
RN2012_L15,,0.4968962713563908,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,,
FSO2013_Ratio H/M normalized Rep2___2,,0.5196028165405622,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,,0.5146165368516625,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,0.5054940861231766,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,,,
CK2022_7 200-1,,0.5026311200450908,
CK2022_5 200-1,,0.5029330037557714,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,0.49945258629659484,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,,0.5008690376023789,
AH2018_SILAC_MR_1_X,,0.5061657588696286,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,0.5094013573436047,
AH2018_SILAC_3_C,,0.5002318845861444,
EJN2021_5_Rest_Ins,,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,0.5014565286113213,
CK2022_4 16-1,,0.502884940926746,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,,,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,0.5076849951653588,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,,0.5108487259765732,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,,0.5105094140587669,
AH2018_SILAC_IT_2_N,,0.5018148230255679,
AH2018_SILAC_IT_1_X,,0.5050166643195789,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,,,
WZ2023_Pe_025_20min,0.6075432544561842,0.5007216138180031,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,0.5070738155490508,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,,0.4994392453171695,0.42039905770038777
RN2012_H06,,0.5062385963274676,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,0.6097387426068938,0.493079691065517,
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,,0.514430989462454,
WZ2023_Su_025_10min,0.6108253122586645,0.49545383617985655,
AH2018_LFQ_IT_4_X,,0.5008594722701062,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.6100958768893926,0.5034550273432405,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.621118749491555,,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,,0.5078650596419909,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,,0.5058553587339144,
EP2017_Untreated R#1 normalized log2 ratio,0.5801182577007572,,
RN2012_L10,,,
PG2020_Intensity 4h_C,,0.47997525198325136,
EP2017_Mitotic R#3 normalized log2 ratio,0.6079996568110975,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,0.515064564120941,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,,0.5050641421819401,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,,0.510809873018052,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,,0.5010382625560107,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,,0.5024505270528281,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.6036092038665638,,
GF2025_P9_Sph,,,
CK2022_6 200-1,,0.5035954128913498,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,,0.4931661724772574,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,0.504580351299401,
PG2020_Intensity 2h_D,,,
EP2017_Untreated R#3 normalized log2 ratio,0.6090117581951119,,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,,0.5027021489072514,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,,0.47834086526713365,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.6199731427738093,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,0.5057934440865036,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,,0.5082866885824687,
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,,,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,,0.50805388268995,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,0.5006569233579489,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,,0.5128698944528367,
EP2017_Untreated R#3 log2 ratio,0.6097388353928873,,
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,,0.5034370862372551,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,,0.5087622062195442,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,,0.5370954345330715,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,,,
YA2020_Reporter_intensity_Normal_No.2,,0.5194353713975851,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,0.6175651344416616,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,0.5086795858482158,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,0.5120069561486177,
CK2022_2 16-1,,0.5025041113141581,
RAM2015_Log2 B,0.6114783869850199,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,0.48841124887664505,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,,,
WZ2023_Su_025_30min,0.6109141385028862,0.49782567944151507,
AH2018_LFQ_4_N,,0.5076166036240478,
CR2017_Ratio Replicate 1.2,,0.5315921239347902,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,0.5183817412648302,
AH2018_SILAC_M_1_X,,0.5064362639912565,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,0.5039849927214566,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,,0.49943493445673526,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,,0.49822807868374114,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,,,
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,,0.5092150349298006,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,,0.5055526982047274,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,,0.5026778904375939,
GF2025_P3_Sph,,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,0.5050862725653905,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,0.48650768454681476,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,,0.5012492259842739,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,,0.5081842772123756,
ZQ2022_N1,,0.5002311136043559,
LY2019_P6-,,0.4995948781596938,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,,0.4996400023515106,
AH2018_LFQ_3_N,,0.5061274403131697,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,,0.5065291315041605,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,,0.497599329355741,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,0.6098317471480997,0.4955024717649025,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,,0.5019327935483809,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,0.49187077600687074,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,,0.5015964898864268,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,,,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,,
EP2017_Pervanadate R#3 log2 ratio,0.6203928870383797,,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,,0.5037787773512888,
AH2018_LFQ_M_4_C,,0.5037494861329608,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,,0.5098090327941959,
CK2022_6 40-1,,0.4980706164528341,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,,0.5091035587544114,
LY2019_P3-,,0.4969510175779588,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,,,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.6093550676633023,0.49470840524238346,
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,,,
AST2020_Control.1,0.6101415166115981,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.6088157330809186,0.4936012282960208,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,,,
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,,0.4939005969088244,0.41003677914203124
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,,0.49967162710961593,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,0.5059010833445937,
LY2019_P8+,,0.5025207674913587,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,,0.42052509486150214
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,0.5073373765587387,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,,0.5123057221064725,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,,
LY2019_P2-,,0.5075567751924078,
AH2018_LFQ_IT_1_X,,0.5062258422103645,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,,
WZ2023_Pe_005_20min,0.6094111923920948,0.48054816316950605,
AST2020_Control.2,0.6100277306443479,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,,0.5016894751961424,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,0.503213672336347,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,,0.5077722920834702,
AH2018_TMTMS3_3_N,,0.49920475735255176,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,0.5045946205197749,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.60859956405383,,
KBE2022_Log2_Ex_36_T,,0.5076602256101452,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.6106721560701759,0.4992683689605454,
KS2014_Intensity C2,,0.5079590369445398,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,,0.5114631187227723,
CK2022_9 200-1,,0.5045086626255928,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,,0.5038813009681377,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,,0.5114887430715525,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,,0.48851688587578335,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,0.5057650923711318,
ZQ2022_C3,,0.5194957195705463,
EJN2021_3_Rest_Ins,,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,,0.5136665861761632,
FSO2013_Ratio H/M normalized Rep3___2,,0.524934695758775,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.5803933434791408,,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.6102875361024644,0.4868951904817621,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,,,
KS2014_Intensity N1,,0.5063456308886533,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,,0.49700716734934364,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,0.5004928708275578,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,0.5020093323904482,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,0.5069279610305039,
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,0.601179717590705,,0.4109103218911405
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,0.6087728901233729,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.608721781302891,0.48271734816354306,
KBE2022_Log2_Ex_29_U,,0.5092305100451413,
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,,0.509422500413023,
AH2018_LFQ_IT_4_N,,0.5030695142309122,
CK2022_15 200-1,,0.5029053093340279,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,0.5106018804389553,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,,0.5110412321085444,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,,0.5041753211122395,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.6095321403587013,0.4979337202665452,
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,0.5011632823852595,
EP2017_Pervanadate R#1 normalized log2 ratio,0.6207635124157626,,
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,,0.5187744897560401,
KBE2022_Log2_Ex_44_U,,0.5100686455671348,
WZ2023_Pe_010_20min,0.6078213347611783,0.48612236320564733,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,,0.49940020969906346,
FSO2013_Ratio H/M normalized Rep3___1,,0.5143122564070536,
AH2018_SILAC_M_3_C,,0.5006679290087968,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,0.5063856040583455,
AH2018_SILAC_M_2_X,,0.505196005723055,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,,0.5099426710634082,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.6112322679107878,0.504500886227052,
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,,0.5096057790426725,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,,0.49561612367907004,0.41668069788671985
CK2022_15 16-1,,0.5032475509423103,
CK2022_3 16-1,,0.5032874739701266,
LY2019_P4-,,0.4997293394789813,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,,,
CK2022_10 16-1,,0.5023129161025129,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,,0.41006556724685117
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.6039486721551544,,
EJN2021_2_Ex_Basal,,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,0.5092946840695505,
AR2021_L41 10 μM,,,
CF2017_EOC 2,,0.49997952696496045,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,,0.5081743604682123,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,,0.4965038311116808,
ZX2022_CB treated Replicate 1,,0.5068569556263042,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,0.49214042539135094,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,,0.49509379389207936,0.4071207758037144
AR2021_L41 1 μM,,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,,0.4981846895887585,0.40773630063838656
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,,0.5083590312143348,
KS2014_Intensity C4,,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,,0.5113793043473094,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,0.5067571494927372,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,,0.5271565800452651,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,,0.5096789498569294,
WZ2023_Pu_025_10min,0.6096591781244536,0.49394350481214927,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,,0.5135261810357857,
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.6081952053897255,0.4923289093637609,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,0.5105654269400837,
KS2014_Intensity C6,,,
ZQ2022_N3,,0.4949289634554351,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,,0.5019620214431127,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,,0.509558413715842,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,,0.5015397010882428,
AH2018_SILAC_IT_2_C,,0.5081065177730356,
CK2022_5 40-1,,0.4975951938510892,
AH2018_LFQ_3_X,,0.5016624858900196,
UK2020_UA_3,,,
LY2019_P7-,,0.49801833857900174,
GF2025_P5_Adh,,,
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5109665818737495,
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,,0.49111233932335807,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,0.5033129894942082,
ZQ2022_C1,,0.5150483373036642,
CR2017_Ratio Replicate 2.1,,0.5046141997429106,
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,0.5023864950715025,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,0.5054333535985024,
YA2020_Reporter_intensity_Cancer_No.4,,0.5216486009716635,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,,,
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,,0.510315637094677,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,,0.5039889423167,
AST2020_anti-CD3+PDL2,0.609210788022495,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,0.50295789536525,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,0.5030163501462004,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,0.608339397771924,,
AH2018_TMTMS2_1_X,,0.4985883471140727,0.4092277203935556
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,,
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,,0.5088069092395359,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,0.5103972133590298,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,,0.5062184031923885,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,,0.4974389479082025,
CF2017_FTE 14,,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,,0.506125519156279,
EP2017_Untreated R#2 normalized log2 ratio,0.6159010559120116,,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,0.5184045678155864,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.6203380854720477,,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
